KP Tissue Stock Forecast, Price & News

-0.09 (-0.86 %)
(As of 06/21/2021 04:00 PM ET)
Today's Range
50-Day Range
52-Week Range
Volume9,383 shs
Average Volume26,567 shs
Market CapitalizationC$101.67 million
P/E RatioN/A
Dividend Yield6.87%
30 days | 90 days | 365 days | Advanced Chart
Receive KPT News and Ratings via Email

Sign-up to receive the latest news and ratings for KP Tissue and its competitors with MarketBeat's FREE daily newsletter.

KP Tissue logo

About KP Tissue

KP Tissue Inc., through its interest in Kruger Products L.P., produces, distributes, markets, and sells a range of disposable tissue products in Canada and the United States. The company operates through two segments, Consumer and Away-From-Home. It offers bathroom and facial tissues, paper towels, and napkins, as well as manufactures private label tissue products. The company markets its products under the Cashmere, Purex, SpongeTowels, Scotties, White Swan, White Cloud, Chalet, Embassy, White Swan, and Metro brand names. The company sells its products to consumers through traditional retail channels, such as grocery stores, mass merchandisers, club and drug stores, convenience stores, and online retailers; and through distributors to businesses involved in commercial users in the property management, healthcare, food services, manufacturing, lodging industries, and public facilities. KP Tissue Inc. was incorporated in 2012 and is headquartered in Mississauga, Canada.


See More Headlines

Industry, Sector and Symbol

Sales & Book Value






Overall MarketRank

1.05 out of 5 stars

Analyst Opinion: 1.0Community Rank: 2.6Dividend Strength: 1.7Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

KP Tissue (TSE:KPT) Frequently Asked Questions

Is KP Tissue a buy right now?

5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for KP Tissue in the last twelve months. There are currently 5 hold ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" KP Tissue stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in KPT, but not buy additional shares or sell existing shares.
View analyst ratings for KP Tissue
or view top-rated stocks.

What stocks does MarketBeat like better than KP Tissue?

Wall Street analysts have given KP Tissue a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but KP Tissue wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is KP Tissue's next earnings date?

KP Tissue is scheduled to release its next quarterly earnings announcement on Thursday, August 5th 2021.
View our earnings forecast for KP Tissue

How were KP Tissue's earnings last quarter?

KP Tissue Inc. (TSE:KPT) posted its quarterly earnings results on Friday, May, 7th. The company reported $0.12 earnings per share for the quarter, topping the Zacks' consensus estimate of $0.09 by $0.03. The company earned $310.38 million during the quarter, compared to analyst estimates of $353.30 million.
View KP Tissue's earnings history

How has KP Tissue's stock been impacted by COVID-19 (Coronavirus)?

KP Tissue's stock was trading at C$11.08 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, KPT shares have decreased by 6.2% and is now trading at C$10.39.
View which stocks have been most impacted by COVID-19

How often does KP Tissue pay dividends? What is the dividend yield for KP Tissue?

KP Tissue announced a quarterly dividend on Friday, May 7th. Shareholders of record on Wednesday, June 30th will be given a dividend of 0.18 per share on Thursday, July 15th. This represents a $0.72 annualized dividend and a yield of 6.93%. The ex-dividend date of this dividend is Tuesday, June 29th.
View KP Tissue's dividend history

Is KP Tissue a good dividend stock?

KP Tissue pays an annual dividend of C$0.72 per share and currently has a dividend yield of 6.87%. KPT has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer.
View KP Tissue's dividend history.

What price target have analysts set for KPT?

5 equities research analysts have issued 12 month price objectives for KP Tissue's stock. Their forecasts range from C$10.00 to C$13.00. On average, they anticipate KP Tissue's share price to reach C$11.42 in the next year. This suggests a possible upside of 9.9% from the stock's current price.
View analysts' price targets for KP Tissue
or view top-rated stocks among Wall Street analysts.

Who are KP Tissue's key executives?

KP Tissue's management team includes the following people:
  • Mr. Dino J. Bianco, Chief Exec. Officer (Age 59, Pay $1.86M)
  • Mr. Mark Holbrook, Chief Financial Officer
  • Mr. Michel Manseau, Sr. VP & GM of Consumer Bus. Canada - Kruger Products LP
  • Mr. Gordon Goss, Sr. VP and GM of Consumer Bus. USA & Mexico - Kruger Products LP
  • Ms. Susan Irving, Chief Marketing Officer of KPLP
  • Mr. Marc James Fitzgerald, Corp. VP of Technology & Product Devel. - Kruger Products LP
  • Mike Baldesarra CPA, CA, Director of Investor Relations
  • Mr. François Paroyan, SVP of Gen. Counsel & Corp. Affairs and Corp. Sec.
  • Mr. Rob Latter, Sr. VP & GM of Away from Home Bus. - Kruger Products LP
  • Ms. Nancy Marcus, Chief Marketing Officer of Kruger Products LP

Who are some of KP Tissue's key competitors?

What other stocks do shareholders of KP Tissue own?

What is KP Tissue's stock symbol?

KP Tissue trades on the Toronto Stock Exchange (TSX) under the ticker symbol "KPT."

How do I buy shares of KP Tissue?

Shares of KPT and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is KP Tissue's stock price today?

One share of KPT stock can currently be purchased for approximately C$10.39.

How much money does KP Tissue make?

KP Tissue has a market capitalization of C$101.67 million.

What is KP Tissue's official website?

The official website for KP Tissue is kptissueinc.com.

Where are KP Tissue's headquarters?

KP Tissue is headquartered at 1900 Minnesota Crt Suite 200, MISSISSAUGA, ON L5N 5R5, Canada.

How can I contact KP Tissue?

KP Tissue's mailing address is 1900 Minnesota Crt Suite 200, MISSISSAUGA, ON L5N 5R5, Canada. The company can be reached via phone at +1-905-8126900.

This page was last updated on 6/21/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.